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Introduction
The understanding of the role of several cancer risk
factors has been enhanced by the analysis of their distrib-
ution in different ethnic groups, as observed in several
sites such as the brain, colon, breast, ovary and others.
Despite the fact that some genetic differences have been
identified, ethnic differences more often point out differ-
ences in the patterns of environmental exposures such as
diet and other lifestyle-related factors.
Several studies carried out in the past decade have
reported higher rates of BRCA1 and BRCA2 gene muta-
tions (mainly 185 delAG, 5382insC and 6174delT) in
Ashkenazi (Eastern and Central Europe ancestry) Jewish
women than in the general population in different coun-
tries [1–6]. This fact has also been associated with a
higher lifetime risk of developing ovarian and breast
cancer among Ashkenazi women, the latter ranging from
38% by age 50 to 59% by age 70 [7].
CPMR = cancer proportional mortality ratios.
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Abstract
Background: Increased BRCA1 and BRCA2 germline mutation rates have been reported in
Ashkenazi Jewish women in North America, Europe and Israel, and have been mentioned as possibly
related to a higher incidence of breast and ovarian cancer among these communities. The present
study was carried out with the aim of obtaining evidence on the magnitude of breast cancer as a cause
of death among Ashkenazi women in Brazil.
Methods: We reviewed all death certificates archived in the Jewish Burial Societies of São Paulo
(1971–1997) and Porto Alegre (1948–1997), two of the main and oldest Jewish communities in
Brazil. Breast cancer observed deaths were compared with expected deaths according to breast
cancer mortality in the general population.
Results: The observed ratios were approximately quite close to unity, suggesting a similar breast
cancer mortality pattern among the Ashkenazi population and the general population in both cities.
These results maintain similar behavior regardless of whether analyzed before or after the mid-1980s,
when mammography came to be increasingly performed in Brazil. Cancer proportional mortality ratios
were 1.04 (0.83–1.29) in São Paulo and 1.16 (0.84–1.57) in Porto Alegre before 1985, and 1.17
(1.00–1.44) and 1.21 (0.81–1.79), respectively, between 1985 and 1997. Some evidence of the
maintenance of protective risk factors such as high parity has been observed among Ashkenazi women
in São Paulo.
Conclusion: A quite similar breast cancer mortality pattern was observed between Ashkenazi Jewish
women and the general population in São Paulo and Porto Alegre, Brazil. These results may suggest
an environmental role on germ mutation expression reported in this ethnic group.
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Different from the reported scientific literature about a
higher breast cancer incidence among Ashkenazi women
in North America and Europe than in the general popula-
tion, breast cancer seems to present a moderate pattern
of occurrence among Brazilian Ashkenazi women. The
objective of this investigation is to evaluate evidence sup-
porting this observation.
This paper presents preliminary results of a comprehen-
sive ascertainment of cancer mortality in two main Jewish
communities in Brazil, São Paulo and Porto Alegre, that
was carried out by searching mortality and personal data
archived in local Jewish burial societies (Chevra Kadisha).
Materials and methods
All death certificates archived from 1 January 1971 to 31
December 1997 in the unique São Paulo Jewish Burial
Society and those from 1 January 1948 to 31 December
1997 in both Porto Alegre Burial Societies were reviewed.
Data on gender, age, nationality, causes of death, and year
of death were obtained for those death certificates that
included any cancer site as a cause of death. Descen-
dants (sons and daughters) were also compiled for all
buried individuals regardless of gender and cause of
death in selected years (1948–1949, 1980 and 1986).
Country of birth, maternal family names and even sur-
names were used to further stratify deaths by origin such
as Ashkenazi or Sepharad (those from North Africa and
Mediterranean origin). The Sepharad usually maintain
special characteristics according to used names and sur-
names, including those related to the nature, to feelings, or
from cities and countries ever inhabited by their ancestors
in the past, thus enabling identification of their origin.
Aiming to evaluate data completeness, we compared
cancer mortality data obtained in the São Paulo Jewish
Burial Society with that provided by the São Paulo popula-
tion-based cancer registry. In a sample of 40 breast
cancer death reports identified in the São Paulo Jewish
Burial Society during selected years (1973–1974, 1983,
1988 and 1997), 38 (95%) could thus be retrieved by the
cancer registry.
Age-adjusted (world population) breast cancer mortality
rates regardless of Jewish origin (Ashkenazi or Sepharad)
were ascertained using a census carried out in the Porto
Alegre Jewish community during 1992 [8], and were
further compared with those observed in the Porto Alegre
general population. This census revealed that almost 95%
of the Jewish families in Porto Alegre were Ashkenazi.
Similar comparisons were not carried out in São Paulo,
where any census of the Jewish community in the past 30
years could be traced.
Expected breast cancer deaths among Ashkenazi women
according to breast cancer mortality patterns in the
Brazilian general population in different age groups in
both cities [9,10] were ascertained and further compared
with observed breast cancer deaths. The expected
number of breast cancer deaths was ascertained for two
different time intervals: before 1985, when mammography
use was quite unavailable in the country; and during the
following years, when this radiologic procedure has
become increasingly performed. The age-standardized
breast cancer proportional mortality in the general popu-
lation, either of São Paulo or Porto Alegre in 1980, was
used to estimate the expected number of breast cancer
deaths during the first interval (1971–1984 in São Paulo
and 1948–1984 in Porto Alegre). Furthermore, breast
cancer proportional mortality in the general population
(according to all cancer site mortality among women of
different age groups in those cities in 1994) was used to
estimate expected deaths among the Jewish population
during 1985–1997. Cancer proportional mortality ratios
(CPMR) (observed versus expected breast cancer
deaths) were therefore obtained in each city and time
interval. Similar procedures were also carried out to
ascertain CPMR for other cancer sites among women,
such as ovary, stomach, colon and rectum, pancreas,
uterus, leukemia and multiple myeloma.
Results
Proportional mortality
Of all cancer deaths among Ashkenazi women in São
Paulo during 1971–1997, 211 (19.5%) were caused by
breast cancer; 71 (22.7%) cancer deaths among Ashke-
nazi women occurred in Porto Alegre during
1948–1997. Younger than age 45, these proportions
were 27.5% in São Paulo (27.3% among Sepharad
women) and 23.5% in Porto Alegre. Cancer proportional
mortality in São Paulo Ashkenazi women (1983–1987)
was 17.8% (16.3% in the general population, 1993),
and that among Porto Alegre Jewish women in
1991–1993 was 26.7% (20.7% in the general popula-
tion, 1991–1993).
Mortality rates
The estimated breast cancer mortality rate in the Porto
Alegre Ashkenazi community (1989–1995) was 108.6/
100,000 women (95% confidence interval [CI],
29.5–278.0) at age 50–59 (56.5/100,000 in the general
population, 1991–1993). At age 60–69, the rates were
77.6 (95% CI, 16.0–226.6) in the community and
98.3/100,000 in the general population, and the rates
were 221.9 (95% CI, 95.6–437.0) and 154.7/100,000,
respectively, among women aged 70 years or older. No
breast cancer deaths were observed among Ashkenazi
women younger than 50 years in Porto Alegre between
1989 and 1995. Age-adjusted breast cancer mortality
rates were hence 24.1/100,000 (95% CI, 13.5–39.7)
among Ashkenazi women and 22.3/100,000 women in
the general population.Breast Cancer Research    Vol 3 No 4 Koifman and Koifman
Cancer proportional mortality ratios
Age-standardized breast cancer proportional mortality
ratios (observed versus expected breast cancer deaths
according to the general population all cancer site mortal-
ity) in Ashkenazi women before 1985 were 1.04 (95% CI,
0.83–1.29) in São Paulo and 1.16 (95% CI, 0.84–1.57)
in Porto Alegre (Table 1). During 1985–1997, the ratios
were 1.17 (95% CI, 1.00–1.44) and 1.21 (95% CI,
0.81–1.79), respectively. Low ratios between observed
versus expected breast cancer deaths were verified in
both time intervals for women younger than 50 years in
São Paulo. A 47% excess of observed over expected
breast cancer deaths was seen among Sepharad women
in São Paulo in almost all age groups (Table 1).
Mean age of death
The breast cancer mean age of death among Ashkenazi
women in São Paulo before 1980 was 62.0 years (stan-
dard error [SE], 1.5 years), and the mean was 57.7 years
in the general population (1979). In the 1980s, the mean
ages were 68.1 years in Ashkenazi women (1981–1989;
SE, 1.5 years) and 59.8 years in the general population
(1988), respectively, while in the 1990s observed
means were 69.3 years among Ashkenazi women
(1990–1997; SE, 1.4 years) and 65.0 years in the
general population (1998).
Mean ages of death among Ashkenazi women in Porto
Alegre were 55.5 years (SE, 2.0 years) before 1980,
65.4 years (SE, 2.3 years) between 1980 and 1989, and
73.4 years (SE, 3.1 years) in the 1990s. In the general
population, the means were, respectively, 59.9 years
(1979), 60.2 years (1988) and 65.6 years (1998).
Discussion
Burial societies have been organized almost everywhere
following the settlement of Jewish communities in Brazil,
and they usually have archived copies of all death certifi-
cates presented by relatives for funeral. Moreover, the
strict rules on burial procedures carried out among Jewish
communities make it feasible to accomplish a comprehen-
sive data completeness, since almost all are buried by
similar community burial societies, regardless of their pre-
vious compliance into observing religious rules.
Table 1
Observed versus expected breast cancer deaths among Ashkenazi and Sepharad Jewish women in São Paulo (1971–1997) and
Porto Alegre (1948–1997), Brazil
São Paulo Ashkenazi São Paulo Sepharad* Porto Alegre
Age group (years) O E O/E 95% CI O E O/E 95% CI O E O/E 95% CI
Before 1985**
20–29 – 1 0.00 – – – 0.00 –
30–39 3 4 0.75 0.15–2.19 4 3 1.33 0.36–3.41
40–49 9 8 1.13 0.52–2.15 6 5 1.20 0.44–2.62
50–64 31 26 1.19 0.80–1.70 20 18 1.11 0.68–1.71
65–79 31 32 0.97 0.65–1.39 11 8 1.38 0.69–2.47
> 79 11 11 1.00 0.50–1.79 1 2 0.50 0.01–2.79
Total 85 82 1.04 0.83–1.29 42 36 1.16 0.84–1.57
1985–1997
20–29 – 1 0.00 – – – 0.00 –
30–39 2 2 1.00 0.12–3.61 2 1 2.00 0.24–1.72 – 1 0.00 –
40–49 5 7 0.71 0.23–1.65 6 4 1.50 0.55–3.50 – 2 0.00 –
50–59 15 14 1.07 0.60–1.77 11 5 2.20 1.10–3.94 5 7 0.71 0.23–1.65
60–69 29 25 1.16 0.78–1.67 10 9 1.11 0.53–2.04 8 5 1.60 0.69–3.15
70–79 40 26 1.54 1.10–2.09 13 6 2.17 1.15–3.71 8 6 1.33 0.57–2.62
> 79 34 30 1.17 0.82–1.63 2 3 0.67 0.08–2.42 8 3 2.67 1.15–5.26
Total 122 104 1.17 1.00–1.44 44 30 1.47 1.07–1.98 29 24 1.21 0.81–1.79
O, Breast cancer observed deaths; E, breast cancer expected deaths; O/E, ratio of observed versus expected breast cancer deaths; 95% CI, 95%
confidence interval estimated by Poisson distribution. * 1971–1997; ** 1948–1997 in Porto Alegre and 1971–1997 in São Paulo.Burial procedures are one of the most important and pre-
served rituals in Jewish tradition, being followed by those
communities everywhere. Organization of such burial soci-
eties and cemeteries was one of the first goals accom-
plished by Jewish immigrants in Brazil and, indeed, their
own communal cemeteries were created in 1908 in Porto
Alegre and in 1923 in São Paulo. Records of all buried
members have usually been archived since then, including
some personal data collected for this study.
Considering that a comprehensive ascertainment on breast
cancer incidence in Brazilian Jewish communities could not
be easily accomplished, we first tried to evaluate breast
cancer mortality in São Paulo and Porto Alegre, where two
of the main Jewish communities in Brazil are situated.
A census of the studied communities enabling mortality
rate ascertainment was only available in Porto Alegre [8].
Despite age-adjusted breast cancer mortality rates being
similar between the Ashkenazi and the general popula-
tions (risk rate, 1.08), higher rates were observed among
the Ashkenazi women at ages 50–59 and 70 years or
older. The absence of reported deaths younger than age
50 years among Porto Alegre Ashkenazi women in
1989–1995 may perhaps reflect a comparatively longer
survival of those affected in the 1980s, comparative with
that observed in the general population.
Comparisons in São Paulo and Porto Alegre were further
carried out using CPMR instead of rates to estimate the
number of expected deaths among Ashkenazi women in
both cities. Despite the fact that CPMR are more robust
indicators than proportional mortality ratios, since variation
on site-specific cancer proportions according to all cancer
deaths is usually shorter than according to all causes of
death, lack of accuracy on these estimates cannot be dis-
missed. Nevertheless, in support of such comparisons, high
reliability and accuracy of reported causes of death from
cancer in Brazil has been previously reported [11–13].
In the present study, we analyzed breast cancer mortality
among Ashkenazi women, but not incidence, and the rela-
tively low overall ratios of observed versus expected
deaths could just reflect a better medical care offered to
this group than to the general population. Nevertheless,
this seems unlikely to explain the low ratios observed
among younger affected women, usually presenting an
aggressive clinical evolution. On the contrary, a better
disease-free survival among Ashkenazi women than in the
general population also seems to be unexpected for
those affected until the mid-1980s, before mammography
availability in Brazil. Origin misclassification (Ashkenazi
versus Sepharad) could also yield data misinterpretation,
but this seems improbable since the majority of reviewed
death certificates were from women born in Eastern and
Central Europe.
Hence, if the relatively low breast cancer proportional mor-
tality ratios observed in São Paulo and Porto Alegre (even
before the mammography era) could also be considered
to indicate a pattern of low breast cancer incidence in
these groups, which indeed was not ascertained in this
study, this fact suggests that environmental exposures
could perhaps act in modulating BRCA1 and/or BRCA2
penetrance, which was previously suggested worthy of
investigation [14]. In other words, these results suggest
that germ mutations seem insufficient to induce higher
breast cancer risks by themselves, but environmental inter-
action would also be necessary to modulate gene expres-
sion related to familial breast cancer. This observation, if
true, could offer an explanation for the different breast
cancer mortality pattern among Ashkenazi women in North
America and Europe comparative with that observed in
São Paulo and Porto Alegre.
The ascertained CPMR for ovarian cancer, colorectal
cancer and multiple myeloma revealed statistically signifi-
cant increased ratios among Ashkenazi women in both
studied cities (Table 2). Because antecedents of familial
aggregation of those cancer sites have been reported to
play an important role in their development, these results
could be considered quite expected, taking into account
the suggested or confirmed higher prevalence of related
mutations among Ashkenazi women, comparative with the
general population, according to such cancer sites
[15–19]. On the contrary, and for the same reasons, a
similar pattern of higher breast cancer mortality ratios
would also be expected among Ashkenazi women, which
indeed was not observed in this study.
In this sense, a protective role to breast cancer yielded by
some lifestyle patterns should be further investigated to
explain such unexpected distribution. A reproductive life
pattern associated with low estrogen exposure (high parity
or long breastfeeding duration) or the adoption of the
typical Brazilian diet, richer in vegetable, beans and fresh
fruit intake [20] than usually observed in North America,
deserve to be analyzed in members of these communities.
Future research should ascertain whether such an environ-
mental profile could have played some role in delaying the
breast cancer age of onset among Ashkenazi women in
Brazil, or even could have inhibited phenotypic expression
of BRCA1 and/or other breast cancer associated genes.
In the case of the São Paulo Jewish Burial Society, infor-
mation regarding relatives was available on reviewed files,
and we could indeed estimate parity evolution along
selected years. These data suggest that the São Paulo
Jewish community seems to have maintained a pattern of
high parity through the past decades. In this sense,
observed parity among buried individuals in 1948–1949
was 3.2, and then it was 2.3 in 1985 and 2.5 in 1996.
These data therefore suggest that parity among Ashkenazi
Available online http://breast-cancer-research.com/content/3/4/270
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[21], remained quite elevated during the past 50 years,
perhaps as a consequence of several reasons, possibly
including a relatively delayed engagement of those women
in the labor force. If this hypothesis is true, trends on
breast cancer incidence will probably change in the future
as the Ashkenazi reproductive pattern seems to be chang-
ing into a similar distribution to that observed in the Brazil-
ian general population (later age at first pregnancy, shorter
parity and breastfeeding reduction).
Such a past breast cancer low-risk pattern among the
Ashkenazi population, whether true and further confirmed,
would be quite unexpected. Carrier rates of BRCA1 or
BRCA2 germline mutations among Ashkenazi women may
be similar wherever they live [22]. Germ mutation rates
among those who immigrated to Brazil may probably
therefore be identical, or very similar, to those observed
among Ashkenazi families who also immigrated to North
America in similar years, and from the same Eastern and
Centro-European regions. In fact, among all reviewed
death certificates from Ashkenazi women in São Paulo
mentioning any cancer site as a cause of death, 807
(74.8%) were born in Central or Eastern Europe, and just
193 (17.9%) in Brazil. In relation to breast cancer, 22.9%
were born in Brazil.
These preliminary results stimulate future data collection
on breast cancer incidence and their joint analysis with
mortality. Both could enhance our understanding of the
possible different patterns of breast cancer development
among Ashkenazi women in Brazil, comparative with those
observed in other countries. Moreover, these results are
suggestive that future research on the genetic aspects
associated with breast cancer development should drive
attention to explore the relationships between environmen-
tal exposures on carcinogenesis, including familial cancer
aggregation. Such research could, perhaps, contribute to
identifying selected risk factors triggering expression of
tumor-related genes associated with breast cancer and
other neoplasia.
Conclusions
Considering the reported higher frequency of BRCA1 and
BRCA2 germline mutations related to breast and ovarian
cancer among Ashkenazi women in different countries, the
results presented in this study were interpreted as showing
a relatively lower than expected breast cancer mortality
pattern among Ashkenazi women in the studied Brazilian
cities. If the breast cancer incidence among Ashkenazi
women in Brazil, which was not evaluated in this study, has
been showing a similar pattern to breast cancer mortality, a
hypothesis can be raised that germ mutations previously
reported among Ashkenazi women may be modulated by
some environmental factors that perhaps could act as pro-
tective factors, delaying the mutation expression.
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